Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results From the Phase II SOLTI-1303 PATRICIA Trial
Clin. Cancer Res 2020 Sep 16;[EPub Ahead of Print], EM Ciruelos, P Villagrasa, T Pascual, M Oliveira, S Pernas, L Paré, S Escrivá-de-Romaní, L Manso, B Adamo, E Martínez de Dueñas, J Cortés, S Vázquez, A Perelló, I Garau, M Melé, N Martínez Jañez, A Montaño, B Bermejo, S Morales, MJ Echarri, E Vega, B González-Farré, D Martínez, P Galván, J Canes, P Nuciforo, X Gonzàlez Farré, A PratFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.